Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkateshwar G Keshamouni

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2016
Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor ProgressionPeter J Chockley, Venkateshwar G Keshamouni
Oncoimmunology|June 28, 2012
Breaking the tolerance for tumor: Targeting negative regulators of TLR signalingTheodore J Standiford, Venkateshwar G Keshamouni
PPAR Research|February 16, 2008
Peroxisome proliferator-activated receptors in lung cancerVenkateshwar G Keshamouni, Shouwei Han, Jesse Roman
The Journal of Biological Chemistry|April 19, 2002
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-deltaVenkateshwar G Keshamouni, Raymond R Mattingly, Kaladhar B Reddy
Proceedings of the American Thoracic Society|October 14, 2005
Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repairTheodore J Standiford, Venkateshwar G Keshamouni, Raju C Reddy
Biochemical and Biophysical Research Communications|May 25, 2017
Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitroZhaolin Chen, Jun Chen, Venkateshwar G Keshamouni, et al.
Molecular Oncology|March 17, 2026
E2A selectively regulates TGF-β-induced apoptosis in KRAS-mutant non-small cell lung cancerSergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, et al.
Pharmaceutics|September 27, 2025
Lysozyme Amyloid for Synthetic RNA DeliveryBenjamin Beluzo, Maytham Ismail, Sergei Chuikov, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 6, 2025
A preliminary investigation into the activity and toxicity of an amyloid-based Emodin formulationAnderson Gattis, Alejandro Hinojosa, Maytham Ismail, et al.
Communications Biology|December 28, 2024
Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transitionRupa Bhowmick, Scott Campit, Shiva Krishna Katkam, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2016
Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor ProgressionPeter J Chockley, Venkateshwar G Keshamouni
Oncoimmunology|June 28, 2012
Breaking the tolerance for tumor: Targeting negative regulators of TLR signalingTheodore J Standiford, Venkateshwar G Keshamouni
PPAR Research|February 16, 2008
Peroxisome proliferator-activated receptors in lung cancerVenkateshwar G Keshamouni, Shouwei Han, Jesse Roman
The Journal of Biological Chemistry|April 19, 2002
Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-deltaVenkateshwar G Keshamouni, Raymond R Mattingly, Kaladhar B Reddy
Proceedings of the American Thoracic Society|October 14, 2005
Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repairTheodore J Standiford, Venkateshwar G Keshamouni, Raju C Reddy
Biochemical and Biophysical Research Communications|May 25, 2017
Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitroZhaolin Chen, Jun Chen, Venkateshwar G Keshamouni, et al.
Molecular Oncology|March 17, 2026
E2A selectively regulates TGF-β-induced apoptosis in KRAS-mutant non-small cell lung cancerSergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, et al.
Pharmaceutics|September 27, 2025
Lysozyme Amyloid for Synthetic RNA DeliveryBenjamin Beluzo, Maytham Ismail, Sergei Chuikov, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 6, 2025
A preliminary investigation into the activity and toxicity of an amyloid-based Emodin formulationAnderson Gattis, Alejandro Hinojosa, Maytham Ismail, et al.
Communications Biology|December 28, 2024
Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transitionRupa Bhowmick, Scott Campit, Shiva Krishna Katkam, et al.
Pageof 5